SILO | NVO | REGN | VRTX | SGEN | ALNY | |
---|---|---|---|---|---|---|
Company Name | Silo Pharma, Inc. | Novo Nordisk A/S | Regeneron Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated | Seagen Inc. | Alnylam Pharmaceuticals, Inc. |
Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Industry | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology |
Market Cap | $5.25M | $597.35B | $128.44B | $127.99B | $43.15B | $33.72B |
Employees | 0.00K | 69.26K | 13.93K | 5.40K | 3.26K | 2.10K |
CEO | Mr. Eric Weisblum | Mr. Lars Fruergaard Jorgensen | Dr. Leonard S. Schleifer M.D., Ph.D. | Dr. Reshma Kewalramani FASN, M.D. | Mr. David R. Epstein B.Sc., M.B.A. | Dr. Yvonne L. Greenstreet M.B.A., MBChB |